Search Results - "Bom, Anton H."
-
1
Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats
Published in Journal of anesthesia (01-04-2011)“…Purpose Sugammadex is a selective relaxant binding agent designed to encapsulate the aminosteroidal neuromuscular blocking agent rocuronium, thereby reversing…”
Get full text
Journal Article -
2
Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey
Published in European journal of anaesthesiology (01-04-2011)“…BACKGROUND AND OBJECTIVE3-Desacetyl-vecuronium is an active metabolite of the neuromuscular blocking agent (NMBA) vecuronium, which might lead to residual…”
Get full text
Journal Article -
3
Org 25969 Causes Rapid Reversal of Rocuronium-Induced Neuromuscular Block, Independent of Acid-Base Status: 2002[A-1009
Published in Anesthesiology (Philadelphia) (01-09-2002)Get full text
Journal Article -
4
Effects of 5-hydroxytryptamine on capillary and arteriovenous anastomotic blood flow in the human hand and forearm and in the pig hind leg
Published in Journal of cardiovascular pharmacology (01-02-1991)“…The effects of intraarterially infused serotonin (5-HT) on capillary and arteriovenous anastomotic (AVA) blood flow were investigated in the hand and forearm…”
Get more information
Journal Article -
5
Carotid haemodynamics in pigs during infusions of 8‐O‐DPAT: reduction in arteriovenous shunting is mediated by 5‐HT1‐like receptors
Published in British journal of pharmacology (01-01-1989)“…1 The effects of intracarotid infusions of 8‐hydroxy‐2‐[di‐n‐propyl‐amino]‐tetralin (8‐OH‐DPAT) on heart rate, blood pressure and carotid blood flow and its…”
Get full text
Journal Article -
6
-
7
Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5‐HT 1 ‐like or 5‐HT 2 receptors
Published in British journal of pharmacology (01-06-1989)“…The potent, antimigraine drug ergotamine has affinity for both 5‐HT 1 and 5‐HT 2 binding sites and constricts arteriovenous anastomoses. Since 5‐HT also…”
Get full text
Journal Article -
8
Characterization of 5-hydroxytryptamine receptors in the cranial vasculature
Published in Cephalalgia (01-01-1989)“…The availability of selective compounds has made it possible to subdivide 5-hydroxytryptamine (5-HT) receptors into three distinct types, called 5-HT1-like,…”
Get more information
Journal Article -
9
The 5-HT1-like receptor mediating reduction of porcine carotid arteriovenous shunting by RU 24969 is not related to either the 5-HT1A or the 5-HT1B subtype
Published in European journal of pharmacology (14-11-1989)“…Using the radioactive microsphere technique in anaesthetized pigs, we studied the systemic and carotid haemodynamic effects of intracarotid infusions (0.3, 1,…”
Get more information
Journal Article -
10
Effects of S9977 and dihydroergotamine in an animal experimental model for migraine
Published in Pharmacological research (01-02-1992)“…The present study concerns the effects of S9977, a trimethylxanthine derivative with potential antimigraine characteristics, on the distribution of carotid…”
Get more information
Journal Article -
11
Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of «5-hydroxytryptamine1-like» receptors
Published in Naunyn-Schmiedeberg's archives of pharmacology (01-07-1986)“…The present study concerns the effects of MDL 72222 (0.5 mg X kg-1, i.v.), a 5-hydroxytryptamine3 (5-HT3) receptor antagonist, and methiothepin (1.0 mg X kg-1,…”
Get full text
Journal Article -
12
Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5‐HT1‐like or 5‐HT2 receptors
Published in British journal of pharmacology (01-06-1989)“…1 The potent, antimigraine drug ergotamine has affinity for both 5‐HT1 and 5‐HT2 binding sites and constricts arteriovenous anastomoses. Since 5‐HT also…”
Get full text
Journal Article